Chromatic fusion: Generative multimodal neuroimaging data fusion provides multi‐informed insights into schizophrenia
Human Brain Mapping · 2023-12 · 44 (17) · 5828-5845
DOI: 10.1002/hbm.26479 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Brain Mapping, online erschienen am 27.09.2023. Verfasst von Eloy P T Geenjaar und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Schizophrenia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIBIB NIH HHS, National Science Foundation, National Institutes of Health.
Abstract (Originalsprache)
This work proposes a novel generative multimodal approach to jointly analyze multimodal data while linking the multimodal information to colors. We apply our proposed framework, which disentangles multimodal data into private and shared sets of features from pairs of structural (sMRI), functional (sFNC and ICA), and diffusion MRI data (FA maps). With our approach, we find that heterogeneity in schizophrenia is potentially a function of modality pairs. Results show (1) schizophrenia is highly multimodal and includes changes in specific networks, (2) non‐linear relationships with schizophrenia are observed when interpolating among shared latent dimensions, and (3) we observe a decrease in the modularity of functional connectivity and decreased visual‐sensorimotor connectivity for schizophrenia patients for the FA‐sFNC and sMRI‐sFNC modality pairs, respectively. Additionally, our results generally indicate decreased fractional corpus callosum anisotropy, and decreased spatial ICA map and voxel‐based morphometry strength in the superior frontal lobe as found in the FA‐sFNC, sMRI‐FA, and sMRI‐ICA modality pair clusters. In sum, we introduce a powerful new multimodal neuroimaging framework designed to provide a rich and intuitive understanding of the data which we hope challenges the reader to think differently about how modalities interact.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA.
- Tri-Institutional Center for Translational Research in Neuroimaging and Data Science (TReNDS), Georgia State, Georgia Tech, Emory, Atlanta, Georgia, USA.
- School of Computational Science and Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA.
- San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.
- Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, California, USA.
- Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, California, USA.
ORCID-Profile: Eloy P T Geenjaar, Noah L Lewis, Lei Wu
Förderung
- NIBIB NIH HHS
- National Science Foundation
- National Institutes of Health
- Georgia Institute of Technology
Zitieren
APA
Geenjaar, E. P. T., Lewis, N. L., Fedorov, A., Wu, L., Ford, J. M., Preda, A., Plis, S. M., & Calhoun, V. D. (2023). Chromatic fusion: Generative multimodal neuroimaging data fusion provides multi‐informed insights into schizophrenia. Human Brain Mapping, 44(17), 5828-5845. https://doi.org/10.1002/hbm.26479
Vancouver
Geenjaar EPT, Lewis NL, Fedorov A, Wu L, Ford JM, Preda A, et al. Chromatic fusion: Generative multimodal neuroimaging data fusion provides multi‐informed insights into schizophrenia. Human Brain Mapping. 2023;44(17):5828-5845. doi:10.1002/hbm.26479
BibTeX
@article{Geenjaar2023,
author = {Geenjaar, Eloy P T and Lewis, Noah L and Fedorov, Alex and Wu, Lei and Ford, Judith M and Preda, Adrian and Plis, Sergey M and Calhoun, Vince D},
title = {Chromatic fusion: Generative multimodal neuroimaging data fusion provides multi‐informed insights into schizophrenia},
journal = {Human Brain Mapping},
year = {2023},
volume = {44},
number = {17},
pages = {5828--5845},
doi = {10.1002/hbm.26479}
}
EUVIMED